Enhancing Regulatory Frameworks

To address societal concerns about our companies' products, we try to work with legislators and regulators to develop and support enhanced regulation and higher manufacturing and marketing standards for the tobacco industry where appropriate.

Federal Regulation of Tobacco Products

Altria Group and Philip Morris USA (PM USA) have supported tough but reasonable federal regulation of tobacco products by the Food & Drug Administration (FDA) for over seven years. We believe that such tough but reasonable federal regulation can benefit shareholders and other stakeholders by ensuring that all tobacco manufacturers and importers doing business in the U.S. operate at the same high standards; by providing a framework for the further pursuit of tobacco product alternatives that are less harmful than conventional cigarettes; and by ensuring transparent, accurate communication about tobacco products to consumers. We remain committed to securing these benefits for our consumers, shareholders and other stakeholders.

On February 15, 2007, Senators Edward Kennedy (D-MA) and John Cornyn (R-TX) and Representatives Henry Waxman (D-CA) and Tom Davis (R-VA) introduced legislation to grant the FDA broad authority to regulate tobacco products. Altria Group and PM USA continue to monitor and engage on the proposed legislation as it moves through the legislative process.

Download
	Altria Group Letter of Endorsement - Senate (pdf 26KB)
	Altria Group Letter of Endorsement - House of Representatives (pdf 26KB)
	You will need Adobe Reader software to view the PDF files on this page.

Related Information

Philip Morris USA Web Resources:

• Philip Morris USA Chairman and CEO Michael E. Szymanczyk's Written Statement Submitted to the Health Subcommittee of the House of Representatives Energy and Commerce Committee in Support of FDA Regulation
• Philip Morris USA Letter of Endorsement
• FDA & Tobacco